Cargando…

RapidPlan head and neck model: the objectives and possible clinical benefit

BACKGROUND: To evaluate a knowledge based planning model for RapidPlan (RP) generated for advanced head and neck cancer (HNC) patient treatments, as well its ability to possibly improve the clinical plan quality. The stability of the model was assessed also for a different beam geometry, different d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogliata, A., Reggiori, G., Stravato, A., Lobefalo, F., Franzese, C., Franceschini, D., Tomatis, S., Mancosu, P., Scorsetti, M., Cozzi, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408433/
https://www.ncbi.nlm.nih.gov/pubmed/28449704
http://dx.doi.org/10.1186/s13014-017-0808-x
_version_ 1783232306370052096
author Fogliata, A.
Reggiori, G.
Stravato, A.
Lobefalo, F.
Franzese, C.
Franceschini, D.
Tomatis, S.
Mancosu, P.
Scorsetti, M.
Cozzi, L.
author_facet Fogliata, A.
Reggiori, G.
Stravato, A.
Lobefalo, F.
Franzese, C.
Franceschini, D.
Tomatis, S.
Mancosu, P.
Scorsetti, M.
Cozzi, L.
author_sort Fogliata, A.
collection PubMed
description BACKGROUND: To evaluate a knowledge based planning model for RapidPlan (RP) generated for advanced head and neck cancer (HNC) patient treatments, as well its ability to possibly improve the clinical plan quality. The stability of the model was assessed also for a different beam geometry, different dose fractionation and different management of bilateral structures (parotids). METHODS: Dosimetric and geometric data from plans of 83 patients presenting HNC were selected for the model training. All the plans used volumetric modulated arc therapy (VMAT, RapidArc) to treat two targets at dose levels of 69.96 and 54.45 Gy in 33 fractions with simultaneous integrated boost. Two models were generated, the first separating the ipsi- and contra-lateral parotids, while the second associating the two parotids to a single structure for training. The optimization objectives were adjusted to the final model to better translate the institutional planning and dosimetric strategies and trade-offs. The models were validated on 20 HNC patients, comparing the RP generated plans and the clinical plans. RP generated plans were also compared between the clinical beam arrangement and a simpler geometry, as well as for a different fractionation scheme. RESULTS: RP improved significantly the clinical plan quality, with a reduction of 2 Gy, 5 Gy, and 10 Gy of the mean parotid, oral cavity and laryngeal doses, respectively. A simpler beam geometry was deteriorating the plan quality, but in a small amount, keeping a significant improvement relative to the clinical plan. The two models, with one or two parotid structures, showed very similar results. NTCP evaluations indicated the possibility of improving (NTCP decreasing of about 7%) the toxicity profile when using the RP solution. CONCLUSIONS: The HNC RP model showed improved plan quality and planning stability for beam geometry and fractionation. An adequate choice of the objectives in the model is necessary for the trade-offs strategies.
format Online
Article
Text
id pubmed-5408433
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54084332017-05-02 RapidPlan head and neck model: the objectives and possible clinical benefit Fogliata, A. Reggiori, G. Stravato, A. Lobefalo, F. Franzese, C. Franceschini, D. Tomatis, S. Mancosu, P. Scorsetti, M. Cozzi, L. Radiat Oncol Research BACKGROUND: To evaluate a knowledge based planning model for RapidPlan (RP) generated for advanced head and neck cancer (HNC) patient treatments, as well its ability to possibly improve the clinical plan quality. The stability of the model was assessed also for a different beam geometry, different dose fractionation and different management of bilateral structures (parotids). METHODS: Dosimetric and geometric data from plans of 83 patients presenting HNC were selected for the model training. All the plans used volumetric modulated arc therapy (VMAT, RapidArc) to treat two targets at dose levels of 69.96 and 54.45 Gy in 33 fractions with simultaneous integrated boost. Two models were generated, the first separating the ipsi- and contra-lateral parotids, while the second associating the two parotids to a single structure for training. The optimization objectives were adjusted to the final model to better translate the institutional planning and dosimetric strategies and trade-offs. The models were validated on 20 HNC patients, comparing the RP generated plans and the clinical plans. RP generated plans were also compared between the clinical beam arrangement and a simpler geometry, as well as for a different fractionation scheme. RESULTS: RP improved significantly the clinical plan quality, with a reduction of 2 Gy, 5 Gy, and 10 Gy of the mean parotid, oral cavity and laryngeal doses, respectively. A simpler beam geometry was deteriorating the plan quality, but in a small amount, keeping a significant improvement relative to the clinical plan. The two models, with one or two parotid structures, showed very similar results. NTCP evaluations indicated the possibility of improving (NTCP decreasing of about 7%) the toxicity profile when using the RP solution. CONCLUSIONS: The HNC RP model showed improved plan quality and planning stability for beam geometry and fractionation. An adequate choice of the objectives in the model is necessary for the trade-offs strategies. BioMed Central 2017-04-27 /pmc/articles/PMC5408433/ /pubmed/28449704 http://dx.doi.org/10.1186/s13014-017-0808-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Fogliata, A.
Reggiori, G.
Stravato, A.
Lobefalo, F.
Franzese, C.
Franceschini, D.
Tomatis, S.
Mancosu, P.
Scorsetti, M.
Cozzi, L.
RapidPlan head and neck model: the objectives and possible clinical benefit
title RapidPlan head and neck model: the objectives and possible clinical benefit
title_full RapidPlan head and neck model: the objectives and possible clinical benefit
title_fullStr RapidPlan head and neck model: the objectives and possible clinical benefit
title_full_unstemmed RapidPlan head and neck model: the objectives and possible clinical benefit
title_short RapidPlan head and neck model: the objectives and possible clinical benefit
title_sort rapidplan head and neck model: the objectives and possible clinical benefit
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408433/
https://www.ncbi.nlm.nih.gov/pubmed/28449704
http://dx.doi.org/10.1186/s13014-017-0808-x
work_keys_str_mv AT fogliataa rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT reggiorig rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT stravatoa rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT lobefalof rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT franzesec rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT franceschinid rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT tomatiss rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT mancosup rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT scorsettim rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit
AT cozzil rapidplanheadandneckmodeltheobjectivesandpossibleclinicalbenefit